Ignota Labs – an innovative company at the intersection of AI and pharmaceuticals – has relocated from London and opened facilities at Cambridge Science Park.
The company, which won the recent OxbridgeAI Challenge, specialises in revitalising drugs with safety issues using its AI platform, SAFEPATH.
SAFEPATH advances the understanding of the root causes of drug toxicity by utilising a causal knowledge graph. This graph intricately maps the relationships and pathways that lead to adverse drug reactions, enabling the identification and mitigation of potential safety issues in pharmaceutical drugs.
Read more:
‘Safety first for Ignota Labs as it relocates AI-Pharma proposition to new Cambridge HQ’ can be read in full at Businessweekly to understand how relocating aligns with our mission of innovation and collaboration.
Authored by: Tony Quested
Published: 30 January 2024 by Businessweekly
Photograph credit: Leebecca Boodhun / Cambridge Science Park
